INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 43h ago
HOUSE PTR3h ago
SEC 13F3h ago
ROBINHOOD CHAIN3h ago
Corporate insider
PA

Pande Atul

DirectorCIK 0001643071

EDGAR filingsOpen in network
Disclosed transactions8
Buys / sells0 / 2
Max Insider Score23
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
PA
Pande AtulDirector
IMVTImmunovant, Inc.
Open-market sale · 10b5-1 plan
SELL$65K
1,500 sh
Aug 28, 2026Aug 28, 2026
traded Aug 28, 2026
+0dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Immunovant, Inc.Director · Apr 9, 2026
0
PA
Pande AtulDirector
IMVTImmunovant, Inc.
Option exercise · 10b5-1 plan
M
$13K
1,500 sh
Aug 28, 2026
Aug 28, 2026
traded Aug 28, 2026
+0d
SEC FORM 4

Evidence

0
PA
Pande AtulDirector
IMVTImmunovant, Inc.
Option exercise · 10b5-1 plan
M—
1,500 sh
Aug 28, 2026Aug 28, 2026
traded Aug 28, 2026
+0dSEC FORM 4

Evidence

0
PA
Pande AtulDirector
IMVTImmunovant, Inc.
Option exercise · 10b5-1 plan
M—
1,500 sh
Jun 26, 2026Jun 26, 2026
traded Jun 26, 2026
+0dSEC FORM 4

Evidence

0
PA
Pande AtulDirector
IMVTImmunovant, Inc.
Option exercise · 10b5-1 plan
M$13K
1,500 sh
Jun 26, 2026Jun 26, 2026
traded Jun 26, 2026
+0dSEC FORM 4

Evidence

23
PA
Pande AtulDirector
IMVTImmunovant, Inc.
Open-market sale · 10b5-1 plan
SELL$57K
1,500 sh
Jun 26, 2026Jun 26, 2026
traded Jun 26, 2026
+0dSEC FORM 4

Evidence

9
PA
Pande AtulDirector
IMVTImmunovant, Inc.
Grant or award
A—
7,061 sh
Apr 7, 2026Apr 9, 2026
traded Apr 7, 2026
+2dSEC FORM 4

Evidence

13
PA
Pande AtulDirector
IMVTImmunovant, Inc.
Grant or award
A—
13.9K sh
Apr 7, 2026Apr 9, 2026
traded Apr 7, 2026
+2dSEC FORM 4

Evidence